| LLY |
Eli Lilly and Company |
0 |
18.35% |
|
|
|
|
|
N/A |
0.00% |
44.40% |
42.16% |
|---|
| BMY |
Bristol-Myers Squibb Company |
0 |
7.03% |
|
|
|
|
|
N/A |
0.00% |
29.50% |
23.55% |
|---|
| NVS |
Novartis AG |
0 |
6.59% |
|
|
|
|
|
N/A |
0.00% |
22.92% |
18.06% |
|---|
| AMGN |
Amgen Inc. |
0 |
6.15% |
|
|
|
|
|
N/A |
0.00% |
27.10% |
20.21% |
|---|
| AZN |
AstraZeneca PLC |
0 |
5.78% |
|
|
|
|
|
N/A |
0.00% |
23.05% |
14.57% |
|---|
| USBGFS7 |
US BANK MMDA - USBGFS 7 06/01/2031 |
|
5.21% |
|
|
|
|
|
|
|
|
|
|---|
| JNJ |
Johnson & Johnson |
0 |
5.17% |
|
|
|
|
|
N/A |
0.00% |
19.70% |
20.31% |
|---|
| PFE |
Pfizer Inc. |
0 |
4.83% |
|
|
|
|
|
N/A |
0.00% |
28.08% |
21.11% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
4.80% |
|
|
|
|
|
N/A |
0.00% |
33.44% |
22.47% |
|---|
| ALKS |
Alkermes plc |
0 |
4.68% |
|
|
|
|
|
N/A |
0.00% |
58.11% |
42.47% |
|---|
| MRK |
Merck & Co., Inc. |
0 |
4.67% |
|
|
|
|
|
N/A |
0.00% |
28.04% |
24.62% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
3.57% |
|
|
|
|
|
N/A |
0.00% |
35.99% |
35.90% |
|---|
| BIIB |
Biogen Inc. |
0 |
3.31% |
|
|
|
|
|
N/A |
0.00% |
28.33% |
18.82% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
3.08% |
|
|
|
|
|
N/A |
0.00% |
46.53% |
42.27% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
2.88% |
|
|
|
|
|
N/A |
0.00% |
57.68% |
34.39% |
|---|
| GSK |
GSK plc |
0 |
2.68% |
|
|
|
|
|
N/A |
0.00% |
27.24% |
44.48% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
1.71% |
|
|
|
|
|
N/A |
0.00% |
66.94% |
41.18% |
|---|
| BCYC |
Bicycle Therapeutics plc |
0 |
1.44% |
|
|
|
|
|
N/A |
0.00% |
1,304.54% |
37.54% |
|---|
| REPL |
Replimune Group, Inc. |
0 |
1.25% |
|
|
|
|
|
N/A |
0.00% |
130.68% |
47.20% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
1.16% |
|
|
|
|
|
N/A |
0.00% |
92.06% |
42.42% |
|---|
| HLN |
Haleon plc |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
406.71% |
58.15% |
|---|
| VNDA |
Vanda Pharmaceuticals Inc. |
0 |
0.87% |
|
|
|
|
|
N/A |
0.00% |
574.32% |
35.27% |
|---|
| LTRN |
Lantern Pharma Inc. |
0 |
0.67% |
|
|
|
|
|
N/A |
0.00% |
1,533.02% |
18.51% |
|---|
| SDZNY |
Sandoz Group AG |
|
0.56% |
|
|
|
|
|
|
|
|
|
|---|
| GEHC |
GE HealthCare Technologies Inc. |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
29.51% |
21.53% |
|---|
| GALT |
Galectin Therapeutics Inc. |
0 |
0.42% |
|
|
|
|
|
N/A |
0.00% |
209.54% |
9.81% |
|---|
| TSVT |
2seventy bio Inc |
|
0.35% |
|
|
|
|
|
|
|
|
|
|---|
| VTRS |
Viatris Inc. |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
36.13% |
41.13% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
0 |
0.29% |
|
|
|
|
|
N/A |
0.00% |
175.10% |
84.73% |
|---|
| EDIT |
Editas Medicine, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
147.29% |
50.55% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
454.42% |
41.52% |
|---|
| Cash&Other |
Cash & Other |
|
0.14% |
|
|
|
|
|
|
|
|
|
|---|
| BLUE |
Bluebird Bio Inc |
|
0.10% |
|
|
|
|
|
|
|
|
|
|---|
| MURA |
Mural Oncology plc |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
206.72% |
19.00% |
|---|
| SLRX |
Salarius Pharmaceuticals, Inc. |
0 |
0.04% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
|---|
| 2368714D |
Pathos AI Inc |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|